Pipeline Flex device with Shield Technology for wide-necked brain aneurysms
Tests a flow diverter device for treating wide-necked brain aneurysms in adults.
Key facts
- Who runs it
- Jacobs institute
- Where
- Buffalo, United StatesSee the site
- Trial code
- Registry title
- Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)
- Status
- Recruiting
- People taking part
- 10 people, planned
- Started
- 1 Jan 2025
- Expected to end
- 1 Jan 2027
- Type of study
- Interventional
- Treatments tested
- SHIELD
- Record updated
- 10 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a large or giant wide-necked brain aneurysm in the internal carotid artery. They will be treated with the Pipeline Flex Embolization Device with Shield Technology.
- Age
- 22 years or older
- Sex
- All sexes can join
- Disease stage
- Large or giant wide-necked intracranial aneurysm (a bulging blood vessel in the brain) in the internal carotid artery, from the petrous to the superior hypophyseal segments.
Main reasons for not taking part
- People who cannot give consent and have no legal representative to give it cannot join.
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Adults (22 years of age or older) with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments
Who cannot take part
- Cannot provide consent or legally authorized representative not available to provide consent Criteria:
Where in United States
- Jacobs InstituteBuffalo, United StatesContact: Carlos Pena, PhD, MSTaking people
About the trial
What the trial wants to find out
The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms
The group in the trial
- SHIELD Study ArmOther group
Active treatment with the Pipeline SHIELD Device
Treatment: SHIELD
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)
- Plain-language title
- Pipeline Flex device with Shield Technology for wide-necked brain aneurysmsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 10 March 2026